Ascendis Pharma
ASND
ASND
173 hedge funds and large institutions have $9.06B invested in Ascendis Pharma in 2020 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 67 increasing their positions, 53 reducing their positions, and 11 closing their positions.
Holders
173
Holders Change
+21
Holders Change %
+13.82%
% of All Funds
3.07%
Holding in Top 10
11
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-8.33%
% of All Funds
0.2%
New
33
Increased
67
Reduced
53
Closed
11
Calls
$29.7M
Puts
$23.4M
Net Calls
+$6.28M
Net Calls Change
-$20.6M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
LCM
176
Laurion Capital Management
New York
| – | -$1M | -6,500 | Closed |
|
|
WC
177
Wexford Capital
West Palm Beach,
Florida
| – | -$772K | -5,000 | Closed |
|
|
PCM
178
Prelude Capital Management
New York
| – | -$515K | -3,340 | Closed |
|
179
Squarepoint
New York
| – | -$489K | -3,166 | Closed |
|
|
VIA
180
Vident Investment Advisory
Alpharetta,
Georgia
| – | -$459K | -2,971 | Closed |
|
|
GCP
181
GSA Capital Partners
London,
United Kingdom
| – | -$413K | -2,676 | Closed |
|
|
VF
182
Virtu Financial
New York
| – | -$276K | -1,787 | Closed |
|
|
CG
183
Cutler Group
San Francisco,
California
| – | -$64K | -420 | Closed |
|
|
QT
184
Quantbot Technologies
New York
| – | -$30K | -200 | Closed |
|